Values First Advisors, Inc. Celldex Therapeutics, Inc. Transaction History
Values First Advisors, Inc.
- $169 Million
- Q1 2024
A detailed history of Values First Advisors, Inc. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Values First Advisors, Inc. holds 19,692 shares of CLDX stock, worth $707,139. This represents 0.49% of its overall portfolio holdings.
Number of Shares
19,692
Previous 7,399
166.14%
Holding current value
$707,139
Previous $293,000
181.91%
% of portfolio
0.49%
Previous 0.18%
Shares
5 transactions
Others Institutions Holding CLDX
# of Institutions
207Shares Held
61.2MCall Options Held
291KPut Options Held
246K-
Wellington Management Group LLP Boston, MA7.65MShares$275 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.51MShares$162 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.65MShares$131 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.12MShares$112 Million2.11% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$111 Million0.02% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.68B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...